jdi12074-sup-0001-FigS1.pdfapplication/PDF15KFigure S1 | Study design and initial dose assignment according to baseline low-density lipoprotein cholesterol levels.
jdi12074-sup-0002-FigS2.pdfapplication/PDF11KFigure S2 | The proportion of participants who achieved their low-density lipoprotein cholesterol targets of lower than 2.6 mmol/L at the end of the 8-week study in the intention-to-treat (ITT) population and the per-protocol (PP) population.
jdi12074-sup-0003-TableS1-S2.docWord document61K

Table S1 | Change from the baseline for high-sensitivity C-reactive protein levels, according to the baseline high-sensitivity C-reactive protein category, and adiponectin levels over the study period

Table S2 | Adverse events

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.